Other languages Evogene Ltd.

Equities

EVGN

IL0011050551

Delayed TEL AVIV STOCK EXCHANGE Other stock markets 03:37:35 26/06/2024 pm IST			5-day change	1st Jan Change
238.5 ^ILa	+2.76%		-0.29%	-20.45%

23/05	Earnings Flash (EVGN) EVOGENE Posts Q1 Revenue $4.2M, vs. Street Est of $3.5M	MT
23/05	Evogene Ltd. Provides Revenue Guidance for the Year 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Evogene Ltd. Provides Revenue Guidance for the Year 2024	23/05
Evogene Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	23/05
Evogene Ltd. and The Kitchen FoodTech Hub Establishes Finally Foods Ltd	02/04
Evogene Receives Minimum Bid Price Non-Compliance Notice From Nasdaq	20/03
Evogene Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	07/03
Evogene Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	07/03
Evogene Unit, Corteva Agriscience Identify New Potential Class of Herbicidal Molecules	06/03
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides	06/03
Casterra Announces New Agreements with Subsidiary of Evogen Ltd., to Meet Growing Demand for Its Elite Castor Seed Varieties	05/03
Evogene Files $200 Million Mixed Shelf	01/03
Evogene Ltd. and Verb Biotics LLC Enters into Collaboration Agreement	06/02
Casterra Ag Ltd., a subsidiary of Evogene Ltd Announces Executive Changes, Effective January 1, 2024	19/12
Evogene Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11
Colors Farm Ltd, Evogene Ltd. and Ben-Gurion University Collaborate to Establish Crustacean Gene Editing Technology	31/23/31
Evogene Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	17/23/17
Evogene Ltd 's ChemPass AI Tech-Engine is Introduces with New Breakthrough Machine Learning Technology for Target-Protein Discovery	25/23/25
Biomica Ltd. Reports Interim Positive Results from Pre-Clinical Studies in its IBS Program	19/23/19
Evogene Expects to Raise $8.5 Million in Gross Proceeds From Registered Direct Offering; Shares Fall	17/23/17
Evogene's Lavie Bio Says Corteva to Develop, Commercialize Lead Fungicide Product Candidates	17/23/17
Evogene Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	18/23/18

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Evogene Ltd.

Equities

EVGN

IL0011050551

Other languages

Filters